Agenus Inc.

AGEN Healthcare Biotechnology

Agenus Inc.’s revenue for fiscal 2025 (year ended December 2025) was $114.2 million, up 10.4% from fiscal 2024. In the quarter to June 2026, revenue grew 34.4%, EPS grew 98.6%, free cash flow fell 55.3% and total debt fell 11.2%, each against the same quarter a year earlier.

6.04 0.64 −9.58%
Market cap
$301.7M
P/E
2.3×
Fwd P/E
4.1×
Dividend yield
—
F-score
4/9
Altman Z
−14.16
Beneish M
12.57
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

0.00 0.00 2.01 1.16
P/S ratio
1.15 0.82 1.02 0.95
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(8.33) (5.62) (3.52) (4.05)
P/B ratio
0.00 0.00 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00
EV/Sales
1.44 1.39 1.17 1.22
EV/EBITDA
0.00 0.00 9.34 3.94
EV/Operating CF
(1.72) (2.05) (1.66) (1.64)
EV/FCF
(1.73) (2.06) (1.67) (1.64)
Quick Ratio
0.03 0.03 0.36 0.32
Current Ratio
0.47 0.41 0.38 0.34
Net Debt/EBITDA
(20.31) 2.78 (0.31) 0.96
Debt/Assets
14.63% 19.69% 16.19% 17.41%
Debt/Equity
(0.12) (0.16) (0.13) (0.15)
Asset Turnover
0.45 0.50 0.64 0.74
Operating CF/Net income
(0.23) 1.56 (0.92) 51.65
Capex/Depreciation
0.03 0.00 0.05 0.46
Interest Coverage
(0.35) 0.90 1.03 0.74
Research and Development Expense of Revenue
78.04% 21.96% 35.04% 42.76%
Selling, General and Administrative Expense of Revenue
35.92% 35.95% 20.33% 24.53%
Intangible Assets out of Total Assets
0.12 0.12 0.15 0.16
Share Based Compensation of Revenue
10.72% 10.12% 3.25% 10.45%
Graham Net Nets
(3.10) (3.98) (2.52) (2.37)
Graham Number
20.25 9.17 0.00 0.00
Earnings Yield
(53.77%) (12.74%) 49.70% 86.48%
Free Cash Flow Yield
(72.46%) (82.30%) (68.76%) (77.60%)
Revenue per Share
0.95 1.15 0.89 0.84
Operating CF per Share
(0.46) (0.56) (0.95) (0.75)
Capex per Share
0.00 0.00 0.00 0.01
Free Cash Flow per Share
(0.46) (0.56) (0.95) (0.75)
Cash per Share
0.11 0.10 0.92 0.45
Shareholders Equity per Share
(8.81) (9.34) (6.01) (4.98)
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(8.81) (9.34) (6.01) (4.98)
Free Cash Flow
(14.66) (16.62) (35.92) (30.96)
Working Capital
(153.18) (190.05) (153.95) (153.01)
Capital Expenditures
0.08 0.00 0.03 0.24
Net Current Asset Value
(380.81) (371.22) (319.15) (299.73)
EV/EBIT
0.00 0.00 17.75 4.46
Capex to Sales
0.00 0.00 0.00 (0.01)
Price to Operating Income
0.00 0.00 15.46 3.49
Other line items
Average Receivables
3.24 3.71 27.21 27.96
Average Payables
65.59 72.23 67.66 66.69
Average Assets
236.19 226.53 193.33 178.96
Average Common Equity
(276.34) (292.14) (275.19) (271.08)

Fold the line items

Columns are period end dates